Louisiana Woman Claims Anti-Depressant Maker did not Warn of Liver Damage

NEW ORLEANS - A Louisiana woman, who claims she now suffers from increased liver enzymes as a result of ingesting Serzone, filed a lawsuit against the Bristol-Myers Squibb Co. alleging it failed to properly warn consumers of potential adverse reactions to the anti-depressant. Van Brunt v. Bristol-Myers Squibb Co. et al., No. 02cv1548 (M.D. La.)

In her complaint filed May 21 in the U.S. District Court for the Middle District of Louisiana, Jerri Van Brunt claims she was unaware of the connection between liver damage and Serzone until April when she heard a news report concerning a class action lawsuit …